Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Sell
42
BAX Quote, Financials, Valuation and Earnings
Last price:
$18.48
Seasonality move
:
4.42%
Day range:
$18.33 - $18.93
52-week range:
$17.40 - $37.74
Dividend yield:
2.81%
P/E ratio:
167.20x
P/S ratio:
0.86x
P/B ratio:
1.31x
Volume:
7.9M
Avg. volume:
8.9M
1-year change:
-44.03%
Market cap:
$9.5B
Revenue:
$10.6B
EPS (TTM):
-$0.52
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
BAX
Baxter International, Inc.
|
$2.9B | $0.60 | 2.57% | 118.69% | $23.80 |
|
ABT
Abbott Laboratories
|
$11.4B | $1.30 | 7.5% | -71.7% | $144.43 |
|
BSX
Boston Scientific Corp.
|
$5B | $0.71 | 15.72% | 105.56% | $126.48 |
|
PODD
Insulet Corp.
|
$679M | $1.15 | 28.59% | 5.39% | $378.21 |
|
RMD
ResMed, Inc.
|
$1.3B | $2.50 | 8.96% | 15.63% | $293.47 |
|
SOLV
Solventum Corp.
|
$2.1B | $1.43 | -5.45% | 768.77% | $84.36 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
BAX
Baxter International, Inc.
|
$18.48 | $23.80 | $9.5B | 167.20x | $0.01 | 2.81% | 0.86x |
|
ABT
Abbott Laboratories
|
$125.40 | $144.43 | $218.1B | 15.73x | $0.59 | 1.88% | 5.00x |
|
BSX
Boston Scientific Corp.
|
$97.72 | $126.48 | $144.9B | 52.27x | $0.00 | 0% | 7.54x |
|
PODD
Insulet Corp.
|
$307.56 | $378.21 | $21.6B | 89.24x | $0.00 | 0% | 8.83x |
|
RMD
ResMed, Inc.
|
$251.44 | $293.47 | $36.7B | 25.73x | $0.60 | 0.9% | 7.04x |
|
SOLV
Solventum Corp.
|
$85.25 | $84.36 | $14.8B | 9.81x | $0.00 | 0% | 1.77x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
BAX
Baxter International, Inc.
|
57.29% | 0.027 | 83.18% | 0.96x |
|
ABT
Abbott Laboratories
|
20.25% | 0.426 | 5.99% | 1.12x |
|
BSX
Boston Scientific Corp.
|
33.99% | 0.345 | 8.31% | 0.81x |
|
PODD
Insulet Corp.
|
42.7% | 1.380 | 4.75% | 1.89x |
|
RMD
ResMed, Inc.
|
12.15% | 0.692 | 2.12% | 1.89x |
|
SOLV
Solventum Corp.
|
50.75% | 0.962 | 40.57% | 0.94x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
BAX
Baxter International, Inc.
|
$938M | $194M | -1.9% | -4.83% | 6.84% | $126M |
|
ABT
Abbott Laboratories
|
$5.9B | $2.2B | 22.49% | 29.06% | 19.03% | $2.3B |
|
BSX
Boston Scientific Corp.
|
$3.3B | $1B | 8.19% | 12.46% | 20.55% | $1.2B |
|
PODD
Insulet Corp.
|
$513.5M | $117.7M | 9.14% | 18.92% | 16.66% | $94.6M |
|
RMD
ResMed, Inc.
|
$808.9M | $462.3M | 22.25% | 25.6% | 34.62% | $411.5M |
|
SOLV
Solventum Corp.
|
$1.1B | $171M | 13.6% | 42.2% | 8.16% | -$21M |
Baxter International, Inc. vs. Competitors
-
Which has Higher Returns BAX or ABT?
Abbott Laboratories has a net margin of -1.8% compared to Baxter International, Inc.'s net margin of 14.07%. Baxter International, Inc.'s return on equity of -4.83% beat Abbott Laboratories's return on equity of 29.06%.
Company Gross Margin Earnings Per Share Invested Capital BAXBaxter International, Inc.33.09% $0.02 $16.9B ABTAbbott Laboratories52.05% $0.91 $64.2B -
What do Analysts Say About BAX or ABT?
Baxter International, Inc. has a consensus price target of $23.80, signalling upside risk potential of 28.79%. On the other hand Abbott Laboratories has an analysts' consensus of $144.43 which suggests that it could grow by 15.18%. Given that Baxter International, Inc. has higher upside potential than Abbott Laboratories, analysts believe Baxter International, Inc. is more attractive than Abbott Laboratories.
Company Buy Ratings Hold Ratings Sell Ratings BAXBaxter International, Inc.2 13 1 ABTAbbott Laboratories15 7 0 -
Is BAX or ABT More Risky?
Baxter International, Inc. has a beta of 0.612, which suggesting that the stock is 38.771% less volatile than S&P 500. In comparison Abbott Laboratories has a beta of 0.716, suggesting its less volatile than the S&P 500 by 28.412%.
-
Which is a Better Dividend Stock BAX or ABT?
Baxter International, Inc. has a quarterly dividend of $0.01 per share corresponding to a yield of 2.81%. Abbott Laboratories offers a yield of 1.88% to investors and pays a quarterly dividend of $0.59 per share. Baxter International, Inc. pays 180.98% of its earnings as a dividend. Abbott Laboratories pays out 29.33% of its earnings as a dividend. Abbott Laboratories's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Baxter International, Inc.'s is not.
-
Which has Better Financial Ratios BAX or ABT?
Baxter International, Inc. quarterly revenues are $2.8B, which are smaller than Abbott Laboratories quarterly revenues of $11.4B. Baxter International, Inc.'s net income of -$51M is lower than Abbott Laboratories's net income of $1.6B. Notably, Baxter International, Inc.'s price-to-earnings ratio is 167.20x while Abbott Laboratories's PE ratio is 15.73x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Baxter International, Inc. is 0.86x versus 5.00x for Abbott Laboratories. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BAXBaxter International, Inc.0.86x 167.20x $2.8B -$51M ABTAbbott Laboratories5.00x 15.73x $11.4B $1.6B
-
Which has Higher Returns BAX or BSX?
Boston Scientific Corp. has a net margin of -1.8% compared to Baxter International, Inc.'s net margin of 14.91%. Baxter International, Inc.'s return on equity of -4.83% beat Boston Scientific Corp.'s return on equity of 12.46%.
Company Gross Margin Earnings Per Share Invested Capital BAXBaxter International, Inc.33.09% $0.02 $16.9B BSXBoston Scientific Corp.65.31% $0.50 $35.7B -
What do Analysts Say About BAX or BSX?
Baxter International, Inc. has a consensus price target of $23.80, signalling upside risk potential of 28.79%. On the other hand Boston Scientific Corp. has an analysts' consensus of $126.48 which suggests that it could grow by 29.43%. Given that Boston Scientific Corp. has higher upside potential than Baxter International, Inc., analysts believe Boston Scientific Corp. is more attractive than Baxter International, Inc..
Company Buy Ratings Hold Ratings Sell Ratings BAXBaxter International, Inc.2 13 1 BSXBoston Scientific Corp.25 2 0 -
Is BAX or BSX More Risky?
Baxter International, Inc. has a beta of 0.612, which suggesting that the stock is 38.771% less volatile than S&P 500. In comparison Boston Scientific Corp. has a beta of 0.673, suggesting its less volatile than the S&P 500 by 32.691%.
-
Which is a Better Dividend Stock BAX or BSX?
Baxter International, Inc. has a quarterly dividend of $0.01 per share corresponding to a yield of 2.81%. Boston Scientific Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Baxter International, Inc. pays 180.98% of its earnings as a dividend. Boston Scientific Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BAX or BSX?
Baxter International, Inc. quarterly revenues are $2.8B, which are smaller than Boston Scientific Corp. quarterly revenues of $5.1B. Baxter International, Inc.'s net income of -$51M is lower than Boston Scientific Corp.'s net income of $755M. Notably, Baxter International, Inc.'s price-to-earnings ratio is 167.20x while Boston Scientific Corp.'s PE ratio is 52.27x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Baxter International, Inc. is 0.86x versus 7.54x for Boston Scientific Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BAXBaxter International, Inc.0.86x 167.20x $2.8B -$51M BSXBoston Scientific Corp.7.54x 52.27x $5.1B $755M
-
Which has Higher Returns BAX or PODD?
Insulet Corp. has a net margin of -1.8% compared to Baxter International, Inc.'s net margin of 12.4%. Baxter International, Inc.'s return on equity of -4.83% beat Insulet Corp.'s return on equity of 18.92%.
Company Gross Margin Earnings Per Share Invested Capital BAXBaxter International, Inc.33.09% $0.02 $16.9B PODDInsulet Corp.72.7% $1.24 $2.4B -
What do Analysts Say About BAX or PODD?
Baxter International, Inc. has a consensus price target of $23.80, signalling upside risk potential of 28.79%. On the other hand Insulet Corp. has an analysts' consensus of $378.21 which suggests that it could grow by 22.97%. Given that Baxter International, Inc. has higher upside potential than Insulet Corp., analysts believe Baxter International, Inc. is more attractive than Insulet Corp..
Company Buy Ratings Hold Ratings Sell Ratings BAXBaxter International, Inc.2 13 1 PODDInsulet Corp.18 2 0 -
Is BAX or PODD More Risky?
Baxter International, Inc. has a beta of 0.612, which suggesting that the stock is 38.771% less volatile than S&P 500. In comparison Insulet Corp. has a beta of 1.374, suggesting its more volatile than the S&P 500 by 37.428%.
-
Which is a Better Dividend Stock BAX or PODD?
Baxter International, Inc. has a quarterly dividend of $0.01 per share corresponding to a yield of 2.81%. Insulet Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Baxter International, Inc. pays 180.98% of its earnings as a dividend. Insulet Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BAX or PODD?
Baxter International, Inc. quarterly revenues are $2.8B, which are larger than Insulet Corp. quarterly revenues of $706.3M. Baxter International, Inc.'s net income of -$51M is lower than Insulet Corp.'s net income of $87.6M. Notably, Baxter International, Inc.'s price-to-earnings ratio is 167.20x while Insulet Corp.'s PE ratio is 89.24x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Baxter International, Inc. is 0.86x versus 8.83x for Insulet Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BAXBaxter International, Inc.0.86x 167.20x $2.8B -$51M PODDInsulet Corp.8.83x 89.24x $706.3M $87.6M
-
Which has Higher Returns BAX or RMD?
ResMed, Inc. has a net margin of -1.8% compared to Baxter International, Inc.'s net margin of 26.1%. Baxter International, Inc.'s return on equity of -4.83% beat ResMed, Inc.'s return on equity of 25.6%.
Company Gross Margin Earnings Per Share Invested Capital BAXBaxter International, Inc.33.09% $0.02 $16.9B RMDResMed, Inc.60.56% $2.37 $7B -
What do Analysts Say About BAX or RMD?
Baxter International, Inc. has a consensus price target of $23.80, signalling upside risk potential of 28.79%. On the other hand ResMed, Inc. has an analysts' consensus of $293.47 which suggests that it could grow by 16.71%. Given that Baxter International, Inc. has higher upside potential than ResMed, Inc., analysts believe Baxter International, Inc. is more attractive than ResMed, Inc..
Company Buy Ratings Hold Ratings Sell Ratings BAXBaxter International, Inc.2 13 1 RMDResMed, Inc.9 6 1 -
Is BAX or RMD More Risky?
Baxter International, Inc. has a beta of 0.612, which suggesting that the stock is 38.771% less volatile than S&P 500. In comparison ResMed, Inc. has a beta of 0.866, suggesting its less volatile than the S&P 500 by 13.363%.
-
Which is a Better Dividend Stock BAX or RMD?
Baxter International, Inc. has a quarterly dividend of $0.01 per share corresponding to a yield of 2.81%. ResMed, Inc. offers a yield of 0.9% to investors and pays a quarterly dividend of $0.60 per share. Baxter International, Inc. pays 180.98% of its earnings as a dividend. ResMed, Inc. pays out 22.3% of its earnings as a dividend. ResMed, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Baxter International, Inc.'s is not.
-
Which has Better Financial Ratios BAX or RMD?
Baxter International, Inc. quarterly revenues are $2.8B, which are larger than ResMed, Inc. quarterly revenues of $1.3B. Baxter International, Inc.'s net income of -$51M is lower than ResMed, Inc.'s net income of $348.5M. Notably, Baxter International, Inc.'s price-to-earnings ratio is 167.20x while ResMed, Inc.'s PE ratio is 25.73x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Baxter International, Inc. is 0.86x versus 7.04x for ResMed, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BAXBaxter International, Inc.0.86x 167.20x $2.8B -$51M RMDResMed, Inc.7.04x 25.73x $1.3B $348.5M
-
Which has Higher Returns BAX or SOLV?
Solventum Corp. has a net margin of -1.8% compared to Baxter International, Inc.'s net margin of 60.4%. Baxter International, Inc.'s return on equity of -4.83% beat Solventum Corp.'s return on equity of 42.2%.
Company Gross Margin Earnings Per Share Invested Capital BAXBaxter International, Inc.33.09% $0.02 $16.9B SOLVSolventum Corp.53.91% $7.22 $10.1B -
What do Analysts Say About BAX or SOLV?
Baxter International, Inc. has a consensus price target of $23.80, signalling upside risk potential of 28.79%. On the other hand Solventum Corp. has an analysts' consensus of $84.36 which suggests that it could fall by -1.04%. Given that Baxter International, Inc. has higher upside potential than Solventum Corp., analysts believe Baxter International, Inc. is more attractive than Solventum Corp..
Company Buy Ratings Hold Ratings Sell Ratings BAXBaxter International, Inc.2 13 1 SOLVSolventum Corp.3 7 1 -
Is BAX or SOLV More Risky?
Baxter International, Inc. has a beta of 0.612, which suggesting that the stock is 38.771% less volatile than S&P 500. In comparison Solventum Corp. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock BAX or SOLV?
Baxter International, Inc. has a quarterly dividend of $0.01 per share corresponding to a yield of 2.81%. Solventum Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Baxter International, Inc. pays 180.98% of its earnings as a dividend. Solventum Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BAX or SOLV?
Baxter International, Inc. quarterly revenues are $2.8B, which are larger than Solventum Corp. quarterly revenues of $2.1B. Baxter International, Inc.'s net income of -$51M is lower than Solventum Corp.'s net income of $1.3B. Notably, Baxter International, Inc.'s price-to-earnings ratio is 167.20x while Solventum Corp.'s PE ratio is 9.81x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Baxter International, Inc. is 0.86x versus 1.77x for Solventum Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BAXBaxter International, Inc.0.86x 167.20x $2.8B -$51M SOLVSolventum Corp.1.77x 9.81x $2.1B $1.3B
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
How High Could NVIDIA Stock Go?
NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…
Stock Ideas
Sell
50
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 61x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 38x
Buy
67
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Sell
47
PSTG alert for Dec 5
Pure Storage, Inc. [PSTG] is up 5.05% over the past day.
Sell
38
HOV alert for Dec 5
Hovnanian Enterprises, Inc. [HOV] is down 22.58% over the past day.
Buy
69
ASTS alert for Dec 5
AST Spacemobile, Inc. [ASTS] is up 18.25% over the past day.
